Researchers at the University of Bath in the UK have developed low-power silicon chips that mimic the electrical activity of neurons. This breakthrough could enable the small chips to function as artificial neurons in numerous implants and medical devices, and the technology has significant potential in treating a wide range of chronic diseases, in (Read more...)
Foundation Fighting Blindness launches retinitis pigmentosa natural history study
A natural history study for people with retinitis pigmentosa caused by mutations in the gene EYS has been launched by the Foundation Fighting Blindness.The 4-year international Rate of Progression in EYE Related Retinal Degeneration (Pro-EYS) study wil…
Limelight Bio Emerges with $75 Million to Develop Next Generation Gene Therapies to Overcome Limitations of Current Treatments
PHILADELPHIA & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Limelight Bio, a privately held, multi-platform, multi-disease biopharmaceutical company developing novel gene therapies, raised $75 million in new financing funded by Apple Tree Partners (ATP), a leadi…
Vivior e SwissLens danno vita a un partenariato per lo sviluppo di lenti a contatto personalizzate
ZURIGO–(BUSINESS WIRE)–Le due società elvetiche accettano di collaborare nel campo della correzione della presbiopia tramite lenti a contatto morbide multifocali personalizzate, nell’obiettivo di ottimizzarne la progettazione utilizzando i dati gener…
Rates of filled opioid prescriptions for incisional ocular surgery increasing
The rates of filled opioid prescriptions for all types of incisional ocular surgery increased over time, according to a study.Researchers evaluated the rates of filled opioid prescriptions, from 1 day before incisional ocular surgery to 7 days after su…
Chris R. Stark Joins EyeCare Services Partners as Vice President, Managed Care
DALLAS–(BUSINESS WIRE)–EyeCare Services Partners (ESP), the national leader in integrated eye care services, announced today that Chris R. Stark recently joined the Company as Vice President, Managed Care. Mr. Stark is responsible for the firm’s cont…